Comerica Incorporated (CMA)

Check out top investors' recommendation for CMA
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
109.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Comerica Incorporated, through its subsidiaries, provides financial products and services primarily in Texas, Arizona, California, Florida, and Michigan. The company operates in three segments: Business Bank, Retail Bank, and Wealth Management. The Business Bank segment offers various products and services, including commercial loans and lines of credit, deposits, cash management, capital market products, international trade finance, letters of credit, foreign exchange management services, and loan syndication services to middle market businesses, multinational corporations, and governmental entities. The Retail Bank segment provides small business banking and personal financial services consisting of consumer lending, consumer deposit gathering, and mortgage loan origination. It also offers various consumer products comprising deposit accounts, installment loans, credit cards, student loans, home equity lines of credit, and residential mortgage loans. The Wealth Management segment provides products and services, including fiduciary services, private banking, retirement services, investment management and advisory services, and investment banking and brokerage services. This segment also sells annuity products, as well as life, disability, and long-term care insurance products. Comerica Incorporated was founded in 1849 and is headquartered in Dallas, Texas.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Ken Usdin Jefferies & Co. Buy   Jun 12, '18     109.00  Jun 12, '19  N/A 
Peter Winter BMO Capital Markets Buy   Apr 09, '18     111.00  Apr 09, '19  N/A 
Marty Mosby Guggenheim Securities LLC Buy   Apr 06, '18     107.00  Apr 06, '19  N/A 
Brian Klock Keefe, Bruyette & Woods Buy   Apr 04, '18     105.00  Apr 04, '19  N/A 
Ken Usdin Jefferies & Co. Buy   Apr 04, '18     109.00  Apr 04, '19  N/A 
Bill Carcache Nomura Buy   Mar 26, '18     117.00  Mar 26, '19  N/A 
Lana Chan BMO Capital Markets Buy   Mar 06, '18     116.00  Mar 06, '19  N/A 
Terry Mcevoy Oppenheimer & Co. Buy   Jan 22, '18     100.00  Jan 22, '19  N/A 
Jon Arfstrom RBC Capital Markets Buy   Jan 16, '18     103.00  Jan 16, '19  N/A 
Brett Rabatin Sterne, Agee & Leach Buy   Jan 16, '18     106.50  Jan 16, '19  N/A 
Ken Usdin Jefferies & Co. Buy   Jan 16, '18     103.00  Jan 16, '19  N/A 
Brian Klock Keefe, Bruyette & Woods Buy   Jan 16, '18     104.00  Jan 16, '19  N/A 
Marty Mosby Guggenheim Securities LLC Buy   Jan 08, '18     97.50  Jan 08, '19  N/A 
Bill Carcache Nomura Buy   Jan 05, '18       Jan 05, '19  N/A 
Jason Goldberg Barclays Sell   Jan 02, '18     93.00  Jan 02, '19  N/A 
Brett Rabatin Sterne, Agee & Leach Buy   Dec 08, '17     98.00  Dec 08, '18  N/A 
David Konrad Macquarie Research Equities Buy   Nov 17, '17     90.00  Nov 17, '18  N/A 
Jon Arfstrom RBC Capital Markets Buy   Oct 17, '17     84.00  Oct 17, '18  N/A 
Ken Usdin Jefferies & Co. Buy   Sep 15, '17     81.00  Sep 15, '18  N/A 
Brett Rabatin Sterne, Agee & Leach Buy   Sep 12, '17     80.00  Sep 12, '18  N/A 
< previous12345